Expression of mutated BRAF (v-raf murine sarcoma viral oncogene homolog B1) V600E mutation induces the transcription of IL1A and IL1B in papillary thyroid carcinoma cells, melanocytes, and melanoma cell lines and this induction can be inhibited by vemurafenib [111,112,113]. Here, BRAF is linked to thyroid gland papillary carcinoma.